Vol. 12, Issue 3 (2023)

Aim: To study the epidemiological, clinical features, laboratory findings, and outcomes of patients diagnosed with Crimean-Congo hemorrhagic fever in 2022 based on data obtained from the statistical department of Al-Salama hospital in Al-Amriya city.

Methods: A cross-sectional study with a total of 29 cases attending Al-Salama Hospital in Al-Ameria in 2022 used particular forms: the first form was for the collection of the following data: age, sex, occupation, residence and clinical presentation; the second form was for scoring cases, The collected data were analyzed by the software SPSS V. 26 (Statistical Package for Social Science).

Results: The study included 29 cases, with 14 females and 15 males. The cases ranged in age from 16 to 72 years old, with an average age of 36 +/- 16 years. The age group (16–30 years) had the most cases (48%), the age group over 50 years had the fewest (17%), eight cases were confirmed with a PCR test, five were probable, and sixteen were suspected, and the fatality rate was zero. Most cases were admitted to Al-Salama Hospital in May (34%). With regard to occupation, 41% were housewives, and none of the cases involved tick-biting-mostly laboratory. Finding thrombocytopenia in the presence of elevated all liver enzymes and INP, the leading clinical features were fever (69%), haemorrhage (59%), headache (45%), nausea, and vomiting (35%). Conclusion: If patients have bleeding manifestations, myalgia, and thrombocytopenia with an elevation of liver enzymes and a history of husbandry at endemic regions, CCHF should be considered.